66 related articles for article (PubMed ID: 7572172)
1. TH1 predominance is associated with improved survival in pediatric medulloblastoma patients.
Wiegering V; Eyrich M; Rutkowski S; Wölfl M; Schlegel PG; Winkler B
Cancer Immunol Immunother; 2011 May; 60(5):693-703. PubMed ID: 21327638
[TBL] [Abstract][Full Text] [Related]
2. Medulloblastoma.
Millard NE; De Braganca KC
J Child Neurol; 2016 Oct; 31(12):1341-53. PubMed ID: 26336203
[TBL] [Abstract][Full Text] [Related]
3. Long time to diagnosis of medulloblastoma in children is not associated with decreased survival or with worse neurological outcome.
Brasme JF; Grill J; Doz F; Lacour B; Valteau-Couanet D; Gaillard S; Delalande O; Aghakhani N; Puget S; Chalumeau M
PLoS One; 2012; 7(4):e33415. PubMed ID: 22485143
[TBL] [Abstract][Full Text] [Related]
4. Local control in non-metastatic medulloblastoma.
Christopherson KM; Bradley JA; Rotondo RL; Pincus DW; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
Acta Oncol; 2014 Sep; 53(9):1151-7. PubMed ID: 24991891
[TBL] [Abstract][Full Text] [Related]
5. Outcome and prognostic factors of radiation therapy for medulloblastoma.
Rieken S; Mohr A; Habermehl D; Welzel T; Lindel K; Witt O; Kulozik AE; Wick W; Debus J; Combs SE
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e7-e13. PubMed ID: 21345611
[TBL] [Abstract][Full Text] [Related]
6. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.
Gajjar A; Chintagumpala M; Ashley D; Kellie S; Kun LE; Merchant TE; Woo S; Wheeler G; Ahern V; Krasin MJ; Fouladi M; Broniscer A; Krance R; Hale GA; Stewart CF; Dauser R; Sanford RA; Fuller C; Lau C; Boyett JM; Wallace D; Gilbertson RJ
Lancet Oncol; 2006 Oct; 7(10):813-20. PubMed ID: 17012043
[TBL] [Abstract][Full Text] [Related]
7. Medulloblastoma--a retrospective analysis.
Awasthy BS; Das Gupta C; Singh R; Patel AK; Julka PK
Indian J Pediatr; 1997; 64(5):693-7. PubMed ID: 10771904
[TBL] [Abstract][Full Text] [Related]
8. Adult medulloblastoma: an analysis of survival and prognostic factors.
Le QT; Weil MD; Wara WM; Lamborn KR; Prados MD; Edwards MS; Gutin PH
Cancer J Sci Am; 1997; 3(4):238-45. PubMed ID: 9263630
[TBL] [Abstract][Full Text] [Related]
9. The therapeutic outcome of medulloblastoma in 49 children.
Jaing TH; Hung IJ; Yang CP; Wang HS; Hung PC
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(4):279-85. PubMed ID: 7572172
[TBL] [Abstract][Full Text] [Related]
10. [High-dose chemotherapy in relapse of medulloblastoma in young children].
Dupuis-Girod S; Hartmann O; Benhamou E; Doz F; Mechinaud F; Bouffet E; Coze C; Kalifa C
Bull Cancer; 1997 Mar; 84(3):264-72. PubMed ID: 9207872
[TBL] [Abstract][Full Text] [Related]
11. Medulloblastoma in adults: clinical characteristics and treatment.
Brandes AA; Palmisano V; Monfardini S
Cancer Treat Rev; 1999 Feb; 25(1):3-12. PubMed ID: 10212586
[TBL] [Abstract][Full Text] [Related]
12. Nevoid basal cell carcinoma syndrome: relation with desmoplastic medulloblastoma in infancy. A population-based study and review of the literature.
Amlashi SF; Riffaud L; Brassier G; Morandi X
Cancer; 2003 Aug; 98(3):618-24. PubMed ID: 12879481
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]